| 56.03 Data as of May 23 |  -0.08 / -0.14%Today’s Change | 36.73 Today|||52-Week Range 56.54 | +33.25% Year-to-Date |
| NPS Pharma Prices Offering - Analyst Blog May 23 / Zacks.com | 2013 FDA Drug Approval Calendar May 21 / TheStreet.com |
| Cubist Pharmaceuticals Inc. (CBST): Today's Featured Health Care Winner May 22 / TheStreet.com | Cubist Reaches New 52-Week High (CBST) May 20 / TheStreet.com |
| Cubist, Optimer, Trius: Antibiotic Deal Making On Tap May 22 / TheStreet.com | Pipeline Progress at Gilead - Analyst Blog May 16 / Zacks.com |
| Cubist Rises On Unusually High Volume (CBST) May 21 / TheStreet.com | Cempra/Toyama Ink Deal - Analyst Blog May 15 / Zacks.com |
| Analysts' Actions: CBST CNW COH TMHC VFC May 21 / TheStreet.com | Synergy Pharma Posts Wider Loss - Analyst Blog May 15 / Zacks.com |
| Previous close | 56.11 |
| Today’s open | 55.11 |
| Day’s range | -- - -- |
| Volume | 821,229 |
| Average volume (3 months) | 882,783 |
| Market cap | $3.7B |
| Dividend yield | -- |
| Earnings growth (last year) | +303.85% |
| Earnings growth (this year) | -40.12% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +22.86% |
| P/E ratio | 32.4 |
| Price/Sales | 2.89 |
| Price/Book | 3.66 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARIAARIAD Pharmaceutical... | +1.01 | +5.48% |
| PRXLPAREXEL Internationa... | +0.51 | +1.12% |
| ISISIsis Pharmaceuticals... | +0.25 | +1.23% |
| CRLCharles River Labora... | +0.33 | +0.75% |
| Next reporting date | July 18, 2013 |
| EPS forecast (this quarter) | $0.39 |
| Annual revenue (last year) | $926.4M |
| Annual profit (last year) | $154.1M |
| Net profit margin | 16.63% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Michael W. Bonney |
President & Chief Operating Officer Robert J. Perez, Jr., MBA |
Corporate headquarters Lexington, Massachusetts |
.
